Abbreviations: AASLD, American Association for the Study of Liver Diseases; AI, artificial
intelligence; ALT, alanine aminotransferase; AST, aspartate aminotransferase; AUROC …

Nonalcoholic fatty liver disease (NAFLD) affects approximately 25‐30% population
worldwide, which progresses from simple steatosis to nonalcoholic steatohepatitis (NASH) …

Background: The purpose of this systematic literature review (SLR) was to evaluate the
accuracy of noninvasive diagnostic tools in detecting significant or advanced (F2/F3) fibrosis …

Background & aims The value of non-invasive tests for monitoring the resolution of
significant liver fibrosis after treatment is poorly investigated. We compared the …

ASMBS Position Statement on the Impact of Metabolic and Bariatric Surgery on
Nonalcoholic Steatohepatitis - Surgery for Obesity and Related Diseases Skip to Main …

Background In patients with clinically severe obesity, metabolic associated fatty liver disease
(MAFLD) and steatohepatitis are highly prevalent. There is a lack of prospective studies …

Non-alcoholic fatty liver disease (NAFLD) is a chronic disease that may lead to cirrhosis and
hepatocellular carcinoma; its close relationship with obesity and the metabolic syndrome …

Background Non-alcoholic fatty liver disease (NAFLD) is the world's most prevalent chronic
liver disease. In advanced stages, it is associated with significant morbidity and mortality …

Nowadays, non-alcoholic fatty liver disease (NAFLD) is considered one of the most
important causes of chronic liver disease in the world. Recent data show a global …

Introdução: Obesidade é um dos principais fatores de risco para desenvolvimento de
doença hepática gordurosa não alcoólica (DHGNA). Não há um exame laboratorial ou …